Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.600 | disputed | 1.000 | 1 | 0 | 2015 | 2016 | ||||||||
|
aladin WD repeat nucleoporin | 0.601 | 0.654 | 2.4E-13 |
|
disease | 0.800 | None | 0.980 | 3 | 0 | 2000 | 2019 | ||||||||
|
alpha and gamma adaptin binding protein | 0.695 | 0.538 | 3.9E-07 |
|
disease | 0.720 | strong | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
alanyl-tRNA synthetase 2, mitochondrial | 0.644 | 0.500 | 5.0E-17 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2020 | ||||||||
|
alanyl-tRNA synthetase 2, mitochondrial | 0.644 | 0.500 | 5.0E-17 |
|
disease | 0.710 | strong | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
alanyl-tRNA synthetase 2, mitochondrial | 0.644 | 0.500 | 5.0E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2018 | ||||||||
|
aminoadipate-semialdehyde synthase | 0.695 | 0.577 | 2.3E-12 |
|
disease | 0.720 | moderate | 1.000 | 3 | 0 | 1968 | 2016 | ||||||||
|
aminoadipate-semialdehyde synthase | 0.695 | 0.577 | 2.3E-12 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 2000 | 2013 | ||||||||
|
aminoadipate-semialdehyde synthase | 0.695 | 0.577 | 2.3E-12 |
|
disease | 0.600 | moderate | 1.000 | 2 | 0 | 2000 | 2013 | ||||||||
|
aminoadipate-semialdehyde synthase | 0.695 | 0.577 | 2.3E-12 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2000 | 2013 | ||||||||
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
disease | 0.700 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.800 | limited | 0.972 | 2 | 0 | 1999 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 1.000 | None | 0.991 | 1 | 0 | 1999 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.700 | limited | 1.000 | 4 | 0 | 2003 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.900 | strong | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.900 | None | 1.000 | 1 | 0 | 2006 | 2016 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
disease | 0.700 | strong | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1998 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 1.000 | limited | 0.995 | 1 | 0 | 1997 | 2020 |